A blog bringing you perspectives from the frontlines of the drug pricing debate.
We took note of two recent POLITICO articles that make very, very clear the reality of what’s going…
Rhetoric in Washington, DC around high and rising drug prices continues to intensify. As Congress considers potential legislation,…
Although Congress has devoted much attention to exploring pharmaceutical manufacturers and pharmacy benefit managers, less attention has been…
As Congress continues to examine the drug supply chain and how to lower prescription drug prices for Americans,…
As Congress returns for a new work period, both parties are renewing their focus on how to bring…
Alex Brill, a senior fellow at the American Enterprise Institute and CEO of Matrix Global Advisors, recently sat…
By: Ed Goeas and Brian Nienaber Read the original post on LinkedIn here. Ahead of the upcoming mid-term…
Americans have overwhelmingly supported action by Congress to lower Big Pharma’s drug prices for years, and now –…
The Biden Administration should work with Congress and act now to eliminate the Rebate Rule, stop damaging Medicare…
On October 1, Matrix Global Advisors’ CEO Alex Brill joined POLITICO health care contributor and podcast host Carol…
